Page last updated: 2024-08-21

malondialdehyde and Phobic Disorders

malondialdehyde has been researched along with Phobic Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atmaca, M; Kuloglu, M; Tezcan, E; Tunckol, H; Ustundag, B1
Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B1

Trials

1 trial(s) available for malondialdehyde and Phobic Disorders

ArticleYear
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment.
    European archives of psychiatry and clinical neuroscience, 2004, Volume: 254, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Catalase; Citalopram; Glutathione Peroxidase; Humans; Malondialdehyde; Oxidoreductases; Phobic Disorders; Superoxide Dismutase

2004

Other Studies

1 other study(ies) available for malondialdehyde and Phobic Disorders

ArticleYear
Antioxidant enzyme and malondialdehyde levels in patients with social phobia.
    Psychiatry research, 2008, May-30, Volume: 159, Issue:1-2

    Topics: Adolescent; Adult; Antioxidants; Catalase; Control Groups; Diagnostic and Statistical Manual of Mental Disorders; Female; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phobic Disorders; Psychiatric Status Rating Scales; Superoxide Dismutase

2008